Sector Focus


Caliber has successfully planned with both venture backed private development stage companies and publicly traded biopharmaceutical companies. We understand the unique challenges of emerging companies as well as global biotech organizations and we have developed a keen sense of what it takes to discover and develop biologically derived treatments to enhance the quality of care in markets with substantially under met medical needs.


Selective Genetics, Inc.

Selective Genetics was a biopharmaceutical company dedicated to the commercialization of site-specific gene therapeutics and DNA devices for tissue repair and regeneration.

Search Projects

  • Senior Vice President, Research and Development